Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs SPYG✓SelectedUSD · SPYGGSK vs SPYG performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs SPYG

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+171.4%
SPYG return
+506.4%
Excess return
-335.0%
Maximum drawdown
-49.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioSPYGExcessAlpha
1D-2.3%-0.8%-1.5%-2.0%
7D-3.0%-3.0%-0.1%-1.8%
30D+0.4%-7.8%+8.2%+3.6%
3M-1.2%-9.4%+8.2%+2.6%
6M+0.9%-6.1%+7.0%+2.8%
YTD+4.0%+4.3%-0.3%+0.9%
1Y+7.3%+7.1%+0.1%+2.9%
3Y+57.1%+81.1%-24.1%+16.3%
5Y+43.0%+60.8%-17.8%+9.4%
10Y+103.1%+372.2%-269.2%-9.5%
All+171.4%+506.4%-335.0%-21.5%

Cumulative growth

Daily Returns

Daily percentage return beside SPYG.

Daily Out/Under-Performance

Portfolio return minus SPYG return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × SPYG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded SPYG wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling